The global blood collection market size was valued at USD 3.73 billion in 2024 and is projected to grow from USD 4.22 billion in 2025 to reach USD 8.34 billion by 2033, exhibiting a CAGR of 8.87% during the forecast period (2025-2033).
The blood collection market is experiencing significant growth due to several key factors. The increasing demand for blood and its components in medical procedures—such as surgeries, diagnostics, and emergency care—is a major contributor. This growth is fueled by a rise in chronic diseases, aging populations, and the increasing need for transfusions in treatments like cancer care and trauma recovery.
Technological advancements also play a critical role in enhancing the market's growth. The development of automated systems, safety features, and more efficient collection devices has improved both the safety and speed of blood collection. As a result, blood collection (venipuncture) processes have become more efficient, reducing risks associated with manual procedures.
Additionally, growing awareness about the importance of blood donation, coupled with advances in healthcare infrastructure, is driving market expansion. Countries with high and upper-middle-income levels tend to have better healthcare systems and more active donation programs, which support higher donation rates. Conversely, the need for blood in lower-income countries presents an opportunity for market growth, particularly through improving donation facilities and raising awareness.
This global shift highlights the significant role collection plays in modern healthcare and the continuous demand for improved collection methods, infrastructure, and awareness campaigns. The market is positioned for further expansion, driven by both technological innovation and global healthcare improvements.
|
Income Levels of Countries |
Blood Donation Rate/1000 people |
|
High-income countries |
31.5 |
|
Upper-middle-income countries |
16.4 |
|
Lower-middle-income countries |
6.6 |
|
Low-income countries |
5.0 |
Source: World Health Organization (WHO)
Another emerging trend is the rise of remote collection, addressing the logistical challenges of traditional blood collection methods. Previously, patients had to visit clinics or hospitals for venipuncture, often leading to delays and inconvenience, particularly in a fast-paced environment. The growing adoption of remote and virtual collection practices is transforming the landscape of blood sample collection.
This trend not only enhances the patient experience but also supports healthcare professionals in performing timely diagnostic and clinical procedures.
The increasing emphasis on preventive healthcare is a significant driver of the global market. As health concerns grow, particularly related to diseases and disabilities, the demand for preventive healthcare measures is rising.
These benefits are supported by regular tests, which are essential for monitoring health and detecting issues early. The growing adoption of preventive healthcare fuels the demand for blood tests, thereby driving the market's expansion.
Regulation of blood collected and its components is very crucial for ensuring the safety and well-being of patients requiring blood transfusion. In the U.S., compliance with guidance documents and FDA regulations is a must for testing, storage, collection, and transport of blood and its components.
For instance, in October 2024, the FDA issued draft guidance offering recommendations to manufacturers requiring FDA approval for blood collection, processing, and storage systems using the Buffy Coat (BC) method to produce blood components for transfusion.
These regulatory frameworks are one of the significant drivers for global market growth, resulting in a patient-centric approach to performing medical examinations by healthcare professionals.
One of the primary restraints in the global market is the risk of contamination during the collection process. Improper handling, insufficient sterilization, or suboptimal storage conditions can lead to contamination, posing significant risks to patient safety. Contaminated blood samples can result in infections or complications if used for medical procedures.
Moreover, blood contamination can weaken the immune system, making individuals more susceptible to infections from even minor health conditions. This risk not only affects patient outcomes but also places a burden on healthcare systems to implement strict protocols and technologies that minimize contamination, limiting market growth.
A growing opportunity in the global market is the increasing demand for apheresis procedures. Apheresis involves the extraction of specific, healthy components from a donor's blood, such as WBCs, platelets, plasma, and RBCs. These components can then be used in patients suffering from disorders such as cancer or cardiovascular diseases, making apheresis a vital part of modern clinical practice.
The rising use of apheresis is driven by its ability to provide targeted therapies for these critical conditions.
As more healthcare facilities adopt apheresis for treating complex medical conditions, the demand for specialized blood collection technologies to support this procedure is expected to rise, offering substantial market growth potential.
| Study Period | 2021-2033 | CAGR | 8.87% |
| Historical Period | 2021-2023 | Forecast Period | 2025-2033 |
| Base Year | 2024 | Base Year Market Size | USD 3.73 Billion |
| Forecast Year | 2033 | Forecast Year Market Size | USD 8.34 Billion |
| Largest Market | North America | Fastest Growing Market | Asia-Pacific |
North America leads the global blood collection market, owing to its advanced healthcare infrastructure that ensures efficient delivery of blood services for patients in need of transfusions, especially those with long-term conditions like cancer. The presence of key industry players also contributes significantly to market growth, driving technological innovations aimed at simplifying the collection process.
Moreover, government initiatives focusing on safe blood distribution and patient care further fuel market expansion. These combined factors make North America a dominant player in the global market, contributing to its continued growth and innovation.
Asia-Pacific is witnessing the fastest growth, driven by a rising number of patients requiring blood transfusions and voluntary blood donation campaigns across the region. Many countries are implementing nationwide initiatives to meet the increasing demand in hospitals and community welfare institutions. Moreover, the adoption of innovative, painless venipuncture technologies is gaining momentum, enhancing healthcare efficiency. These factors contribute to the rapid market expansion in the Asia-Pacific, positioning it as a key growth region for blood collection technologies and services.
The global market is experiencing dynamic growth and diversification across the globe, with each country contributing uniquely to the advancement of this transformative field. Below are a few countries that illustrate the diverse contributions and advancements in the global market.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global blood collection market is segmented into collection site, method, application, and end-user.
Venous segment dominates the market with the highest market revenue
The venous segment leads the global market due to its ability to quickly and efficiently withdraw a specified amount of blood. This method is particularly useful for chronic illnesses like cancer and diabetes, where regular screenings are essential for diagnosis and monitoring. The convenience and speed of venous collection make it the preferred method for ongoing testing. For example, in April 2022, Owen Mumford introduced new venous venipuncture devices to enhance efficiency and meet growing market demand.
Manual segment dominates the market with the highest market revenue
The manual collection segment dominates the market due to its long-established use and practicality, especially in regions with limited healthcare infrastructure. In many areas, automated or high-tech collection devices are unavailable, making manual collection the most widely practiced method. Despite technological advances, manual venipuncture remains the primary technique in areas lacking resources, ensuring its continued market dominance. The ease of use and low cost of manual methods further contribute to its widespread adoption across diverse geographies.
Diagnostics segment dominates the market with the highest market revenue
The diagnostics segment is the leading revenue generator in the global market, as accurate diagnostic testing requires regular samples. Venipuncture is essential for monitoring medical conditions that demand frequent testing, such as diabetes, cardiovascular diseases, and infections. As clinical examinations in laboratories rely heavily on blood samples, the demand for diagnostic venipuncture continues to grow. The need for timely and accurate results drives the dominance of the diagnostics segment.
Hospitals segment dominates the market with the highest market revenue.
Hospitals dominate the collection market due to their central role in diagnostics and patient care. Hospitals are the primary setting for blood tests, clinical examinations, and emergency procedures, making them the largest consumers of blood collection equipment. In-house laboratories and emergency units increase the frequency of venipuncture, further boosting demand. As the first point of care for many patients, hospitals generate the highest revenue from collection devices, solidifying their dominant position in the market.
Key market players in the global market are strategically investing in product innovation and expanding their product portfolios to meet growing consumer demand for convenience, safety, and sustainability. Companies are focusing on developing painless and easy-to-handle equipment for blood collection from patients.
Retractable Technologies, Inc.: An emerging player
Retractable Technologies, Inc. is an emerging player in the global market, gaining attention for its innovative products and solutions for venipuncture. The company offers uniquely designed syringes, needles, and blood collection tube holders with needle and blood collection sets that prevent contamination by reuse and promote reduction in linked costs and disposals.
As per our analysts, the global blood collection market is on a path of significant growth, driven by rising awareness of the importance of blood donation and the proactive role of government initiatives in ensuring safe and efficient processes for blood withdrawal, storage, and distribution. Emerging technological advancements and innovative solutions are enhancing the efficiency, accuracy, and accessibility of blood collection, broadening its global reach.
Moreover, the implementation of stringent regulatory frameworks ensures seamless and reliable practices, fostering trust and quality in the market. The growing demand for whole blood and its components, particularly for treating critical medical conditions, serves as a key driver propelling the market’s robust expansion.
